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Background
During maturation of soluble guanylyl cyclase (sGC),
heme insertion into the beta subunit is essential because it
enables sGC to recognize nitric oxide (NO) and transduce
its biological effects. We used a mammalian cell culture
approach and followed heme insertion into both transi-
ently- and endogenously-expressed apo-sGC beta.
Although sGC is often associated with heat shock protein
90 (hsp90) in cells, the implications are unclear. Experi-
ments that used pharmacological hsp90 inhibitors, an
ATP-ase inactive hsp90 mutant, and heme-dependent or
heme-independent sGC activators revealed that heme
insertion into apo-sGC requires hsp90 [1].
Results
Our findings suggest a model where apo-sGC beta may
directly complex with hsp90, which then drives heme
insertion into apo-sGC beta through its inherent ATPase
activity. In follow-up studies we are using purified proteins
and domains and fluorescence and hydrogen-deuterium
exchange methods to characterize the apo-sGC interaction
with hsp90 at the molecular level. Results indicate that
apo-sGC beta binds to the hsp90 middle domain, and the
binding interaction involves structural regions within the
heme and PAS domains of sGC.
Conclusion
Together, our work is shedding light on the sGC matura-
tion process, and is revealing new ways that sGC activity
could be impacted or controlled in cells.
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